Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2025 |
Dec. 31, 2024 |
| Summary of Significant Accounting Policies |
|
|
| Schedule of cost of revenue |
| | Three Months Ended | | | Nine months ended | | | | September 30, | | | September 30, | | | | 2025 | | | 2024 | | | 2025 | | | 2024 | | Cost of inventory | | $ | 494,144 | | | $ | 98,637 | | | $ | 1,315,378 | | | $ | 233,362 | | Freight and shipping | | | 15,665 | | | | 1,171 | | | | 21,724 | | | | 9,321 | | Consulting and advisory-related party | | | - | | | | 5,800 | | | | 4,000 | | | | 16,200 | | Royalty and sales commission-related party | | | - | | | | 20,456 | | | | 91,290 | | | | 83,192 | | Rent expense | | | 65,794 | | | | 39,373 | | | | 166,863 | | | | 95,562 | | Total cost of revenue | | $ | 575,603 | | | $ | 165,437 | | | $ | 1,599,255 | | | $ | 437,637 | |
|
| | Years Ended | | | | December 31, | | | | 2024 | | | 2023 | | Cost of inventory | | $ | 407,334 | | | $ | 101,978 | | Freight and shipping | | | 9,321 | | | | 14,494 | | Consulting and advisory-related party | | | 19,400 | | | | 30,100 | | Royalty and sales commission-related party | | | 81,917 | | | | 47,304 | | Rent expense | | | 137,527 | | | | 66,258 | | Total cost of revenue | | $ | 655,499 | | | $ | 260,134 | |
|
| Schedule of antidilutive securities |
| | September 30, | | | September 30, | | | | 2025 | | | 2024 | | | | Shares | | | Shares | | Convertible notes | | | 1,266,987 | | | | 467,083 | | Common Stock warrants | | | 1,925,768 | | | | 233,542 | | Series C Convertible Preferred Stock | | | 2,545,667 | | | | 8,281,673 | | | | | 5,738,422 | | | | 8,982,298 | |
|
| | December 31, | | | December 31, | | | | 2024 | | | 2023 | | | | Shares | | | Shares | | Convertible notes | | | 3,240,000 | | | | 300,000 | | Common stock warrants | | | 1,620,000 | | | | - | | Convertible Series C Preferred Stock | | | 51,923,443 | | | | 19,347,886 | | Convertible Series A Preferred Stock(1) | | | - | | | | 10,000,000,000 | | | | | 56,783,443 | | | | 10,019,647,886 | |
|
| Schedule of deferred offering costs |
| | September 30, | | | December 31, | | | | 2025 | | | 2024 | | Professional fees | | $ | - | | | $ | 52,131 | | General and administrative expenses | | | - | | | | 73,973 | | | | $ | - | | | $ | 126,104 | |
|
| | December 31, | | | December 31 | | | | 2024 | | | 2023 | | Legal fees | | $ | 52,131 | | | $ | - | | General and administrative expenses | | | 73,973 | | | | - | | Total | | $ | 126,104 | | | $ | - | |
|
| Schedule of stock-based compensation |
| | Three Months Ended | | | Nine months ended | | | | September 30, | | | September 30, | | | | 2025 | | | 2024 | | | 2025 | | | 2024 | | Management compensation | | $ | 1,810,379 | | | $ | - | | | $ | 4,098,768 | | | $ | - | | Professional fees (*) | | | 313,807 | | | | (200,000 | ) | | | 578,227 | | | | 2,050,000 | | Professional fees - related party | | | - | | | | - | | | | 2,103,600 | | | | 348,000 | | Advertising and marketing | | | - | | | | - | | | | - | | | | 160,000 | | Financing expense | | | - | | | | - | | | | 8,679,189 | | | | - | | | | $ | 2,124,186 | | | $ | (200,000 | ) | | $ | 15,459,784 | | | $ | 2,558,000 | |
|
| | Years Ended | | | | December 31, | | | | 2024 | | | 2023 | | Management compensation | | $ | - | | | $ | 180,000 | | Professional fees | | | 975,249 | | | | 146,850 | | Professional fees - related party | | | 1,422,750 | | | | 8,640,000 | | Advertising and marketing | | | 660,000 | | | | - | | | | $ | 3,057,999 | | | $ | 8,966,850 | |
|
| Schedule of liabilities measured at fair value on a recurring basis |
December 31, 2024 | | Level 3 | | Liabilities | | | | Derivative Liability – conversion feature | | $ | 1,055,233 | |
|
|
| Schedule of antidilutive securities excluded from the computation of eps |
|
| | Years Ended | | | | December 31, | | | | 2024 | | | 2023 | | Numerator: | | | | | | | Net loss | | $ | (6,881,722 | ) | | $ | (10,102,266 | ) | Change in fair value of derivatives | | | 409,776 | | | | - | | Interest on convertible debts | | | 50,723 | | | | 1,311 | | Net loss - diluted | | $ | (6,421,223 | ) | | $ | (10,100,955 | ) | | | | | | | | | | Denominator: | | | | | | | | | Weighted average common shares outstanding | | | 8,382,753 | | | | 16,110,578 | | Effect of dilutive shares | | | | | | | | | Convertible notes | | | 212,248 | | | | 50,000 | | Preferred stock | | | 8,653,960 | | | | 169,891,314 | | Common stock warrants | | | 32,548 | | | | - | | Diluted | | | 17,281,456 | | | | 186,051,893 | | | | | | | | | | | Net income per common share: | | | | | | | | | Basic | | $ | (0.82 | ) | | $ | (0.63 | ) | Diluted | | $ | (0.37 | ) | | $ | (0.01 | ) |
|